EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 359 filers reported holding EXELIXIS INC in Q1 2023. The put-call ratio across all filers is 0.23 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $388,865 | +14.4% | 17,797 | +0.0% | 0.00% | – |
| Q2 2023 | $339,967 | -18.2% | 17,790 | -16.9% | 0.00% | – |
| Q1 2023 | $415,511 | +23.0% | 21,407 | +1.6% | 0.00% | – |
| Q4 2022 | $337,883 | -0.9% | 21,065 | -2.9% | 0.00% | – |
| Q3 2022 | $341,000 | -22.5% | 21,695 | +2.5% | 0.00% | – |
| Q2 2022 | $440,000 | -8.9% | 21,156 | -0.7% | 0.00% | – |
| Q1 2022 | $483,000 | +23.8% | 21,301 | -0.4% | 0.00% | – |
| Q4 2021 | $390,000 | -19.4% | 21,377 | -6.8% | 0.00% | – |
| Q3 2021 | $484,000 | +19.5% | 22,937 | +3.0% | 0.00% | – |
| Q2 2021 | $405,000 | -19.8% | 22,260 | -0.3% | 0.00% | – |
| Q1 2021 | $505,000 | +31.9% | 22,333 | +17.2% | 0.00% | – |
| Q4 2020 | $383,000 | -0.3% | 19,063 | +21.4% | 0.00% | – |
| Q3 2020 | $384,000 | -3.5% | 15,704 | -6.5% | 0.00% | -100.0% |
| Q2 2020 | $398,000 | +83.4% | 16,804 | +33.4% | 0.00% | – |
| Q1 2020 | $217,000 | 0.0% | 12,592 | +2.1% | 0.00% | – |
| Q4 2019 | $217,000 | +4.3% | 12,332 | +4.9% | 0.00% | – |
| Q3 2019 | $208,000 | -31.1% | 11,756 | -16.8% | 0.00% | – |
| Q2 2019 | $302,000 | -66.1% | 14,131 | -62.3% | 0.00% | -100.0% |
| Q1 2019 | $892,000 | +91.4% | 37,499 | +58.2% | 0.00% | 0.0% |
| Q4 2018 | $466,000 | +6.9% | 23,698 | -3.3% | 0.00% | – |
| Q3 2018 | $436,000 | +401.1% | 24,519 | +508.0% | 0.00% | – |
| Q2 2018 | $87,000 | -15.5% | 4,033 | -13.8% | 0.00% | – |
| Q1 2018 | $103,000 | -88.1% | 4,678 | -83.6% | 0.00% | -100.0% |
| Q4 2017 | $867,000 | -45.7% | 28,535 | -56.8% | 0.00% | -50.0% |
| Q3 2017 | $1,598,000 | -72.4% | 66,004 | -71.9% | 0.00% | -66.7% |
| Q2 2017 | $5,788,000 | +3.0% | 234,997 | -9.3% | 0.01% | 0.0% |
| Q1 2017 | $5,617,000 | +54.0% | 259,210 | +6.0% | 0.01% | +50.0% |
| Q4 2016 | $3,647,000 | +12925.0% | 244,517 | +11014.4% | 0.00% | – |
| Q3 2016 | $28,000 | +75.0% | 2,200 | +12.1% | 0.00% | – |
| Q2 2016 | $16,000 | +128.6% | 1,962 | -2.4% | 0.00% | – |
| Q1 2016 | $7,000 | -97.1% | 2,011 | -95.3% | 0.00% | – |
| Q4 2015 | $242,000 | +106.8% | 42,587 | +104.2% | 0.00% | – |
| Q3 2015 | $117,000 | +1200.0% | 20,855 | +789.7% | 0.00% | – |
| Q2 2015 | $9,000 | +80.0% | 2,344 | +44.7% | 0.00% | – |
| Q1 2015 | $5,000 | +25.0% | 1,620 | -55.2% | 0.00% | – |
| Q4 2014 | $4,000 | -76.5% | 3,620 | -68.8% | 0.00% | – |
| Q3 2014 | $17,000 | -10.5% | 11,620 | +106.8% | 0.00% | – |
| Q2 2014 | $19,000 | +111.1% | 5,620 | +114.5% | 0.00% | – |
| Q1 2014 | $9,000 | -25.0% | 2,620 | +31.0% | 0.00% | – |
| Q4 2013 | $12,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q3 2013 | $12,000 | +33.3% | 2,000 | 0.0% | 0.00% | – |
| Q2 2013 | $9,000 | – | 2,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $265,294,000 | 64.62% |
| Sargent Investment Group, LLC | 465,620 | $8,234,000 | 3.70% |
| Orbimed Advisors | 3,912,900 | $69,200,000 | 1.31% |
| Bellevue Group AG | 3,858,700 | $68,241,000 | 1.27% |
| TEALWOOD ASSET MANAGEMENT INC | 137,129 | $2,425,000 | 1.04% |
| CAPITAL MANAGEMENT CORP /VA | 200,995 | $3,555,000 | 0.97% |
| Penn Capital Management Company, LLC | 517,988 | $9,161,000 | 0.96% |
| Chicago Capital, LLC | 801,560 | $14,176,000 | 0.95% |
| Portolan Capital Management | 454,444 | $8,037,000 | 0.91% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 103,534 | $1,830,000 | 0.85% |